Precision Optics Corp. (NASDAQ:POCI) Sees Significant Increase in Short Interest

Precision Optics Corp. (NASDAQ:POCI) was the target of a large growth in short interest during the month of January. As of January 30th, there was short interest totaling 19,981 shares, a growth of 57.7% from the January 15th total of 12,674 shares. Currently, 0.3% of the shares of the stock are short sold. Based on an average daily trading volume, of 28,639 shares, the days-to-cover ratio is currently 0.7 days. Based on an average daily trading volume, of 28,639 shares, the days-to-cover ratio is currently 0.7 days. Currently, 0.3% of the shares of the stock are short sold.

Hedge Funds Weigh In On Precision Optics

A number of institutional investors have recently modified their holdings of POCI. Geode Capital Management LLC boosted its position in Precision Optics by 3.4% during the fourth quarter. Geode Capital Management LLC now owns 58,436 shares of the company’s stock worth $245,000 after acquiring an additional 1,926 shares during the last quarter. DRW Securities LLC acquired a new position in Precision Optics in the 4th quarter valued at $94,000. Citadel Advisors LLC purchased a new position in shares of Precision Optics during the 3rd quarter worth $49,000. Finally, Jane Street Group LLC acquired a new stake in shares of Precision Optics during the fourth quarter worth $48,000. Institutional investors and hedge funds own 13.71% of the company’s stock.

Precision Optics Stock Performance

NASDAQ POCI opened at $4.76 on Friday. The company has a quick ratio of 0.79, a current ratio of 1.29 and a debt-to-equity ratio of 0.10. Precision Optics has a fifty-two week low of $3.77 and a fifty-two week high of $6.04. The business has a fifty day moving average of $4.57 and a 200-day moving average of $4.51. The stock has a market cap of $36.75 million, a price-to-earnings ratio of -5.67 and a beta of 0.32.

Precision Optics (NASDAQ:POCI) last posted its quarterly earnings data on Thursday, November 13th. The company reported ($0.21) EPS for the quarter. Precision Optics had a negative net margin of 28.31% and a negative return on equity of 53.29%. The company had revenue of $6.68 million for the quarter.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Precision Optics in a research note on Thursday, January 22nd. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Precision Optics has a consensus rating of “Sell”.

Precision Optics Company Profile

Precision Optics Corporation, Inc designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians.